NCT04096131 (DICAT-II) is a clinical trial of cataract surgery in Diabetic Macular Edema, sponsored by European School of Advanced Studies in Ophthalmology.

Who is sponsoring NCT04096131?

NCT04096131 is sponsored by European School of Advanced Studies in Ophthalmology.

What drugs are being tested in NCT04096131?

Interventions in NCT04096131: cataract surgery.

What condition does NCT04096131 study?

NCT04096131 studies Diabetic Macular Edema, Cataract Senile, Surgery--Complications.

Is NCT04096131 still recruiting?

NCT04096131 is currently completed. Last updated 16 August 2021.

Last reviewed 2021-08-16 · How we verify

NCT04096131: DICAT-II

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Cataract Surgery on Early DME The DICAT-II Study

Completed Last updated 16 August 2021

What this trial tests

trial testing cataract surgery in Diabetic Macular Edema in 143 participants. Completed in 31 January 2021.

Timeline

28 January 2020

Primary endpoint
30 November 2020

31 January 2021

Quick facts

Lead sponsor	European School of Advanced Studies in Ophthalmology
Status	Completed
Study type	OBSERVATIONAL
Enrollment	143
Start date	28 January 2020
Primary completion	30 November 2020
Estimated completion	31 January 2021
Sites	1 location across Switzerland

Drugs / interventions tested

cataract surgery — full drug profile →

Conditions studied

Diabetic Macular Edema — all drugs for Diabetic Macular Edema →
Cataract Senile — all drugs for Cataract Senile →
Surgery--Complications — all drugs for Surgery--Complications →

Sponsor

European School of Advanced Studies in Ophthalmology

Who can join

Adults 55 to 80, any sex, with Diabetic Macular Edema or Cataract Senile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine if cataract surgery may have an impact on the natural history of early DME (E-DME)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early DMO: a predictor of poor outcomes following cataract surgery in diabetic patients. The DICAT-II study.
Panozzo G, Mura GD, Franzolin E, Giannarelli D, et al · · 2022 · cited 5× · PMID 34345028 · DOI 10.1038/s41433-021-01718-4

Verify or expand the search:

Other trials of cataract surgery

Trials testing the same drug.

NCT06658119 — Clinical Evaluation of Extended Depth-of-focus Intraocular Lens in Refractive Cataract Surgery: a Randomized Controlled · NA · recruiting
NCT06505096 — A Comparative Study of the Results of Dynamic and OPD Static Measurement of Pupil Diameter Before and After Cataract Sur · not yet recruiting
NCT05718076 — Trifocal Intraocular Lens in High Myopic Patients With Different Meta-PM Grading · unknown
NCT06708806 — Cell Ongrowth and Biocompatibility Study of Two Different (Hydrophobic Acrylic) Intraocular Lenses: IOL XY1 vs. IOL XY1A · NA · completed
NCT04931277 — Stepped Surgery in Uveitic Cataract: A Novel Approach to a Quiet Eye · NA · completed

Other recruiting trials for Diabetic Macular Edema

Currently open trials in the same condition.

NCT07425522 — A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With D · Phase 1 · recruiting
NCT06984822 — Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant · NA · recruiting
NCT07038967 — Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification · recruiting
NCT06680817 — A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study) · recruiting
NCT06549023 — Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy · NA · recruiting

Other European School of Advanced Studies in Ophthalmology trials

Trials by the same sponsor.

NCT05080803 — Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04096131 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by European School of Advanced Studies in Ophthalmology
Last refreshed: 16 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04096131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing